Vanguard Personalized Indexing Management, LLC Beam Therapeutics Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $4.59 Billion
- Q1 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 7,630 shares of BEAM stock, worth $197,922. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,630Holding current value
$197,922% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding BEAM
# of Institutions
244Shares Held
65.5MCall Options Held
311KPut Options Held
777K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.18MShares$212 Million1.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.58MShares$197 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.71MShares$174 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.51MShares$117 Million0.7% of portfolio
-
Morgan Stanley New York, NY4.12MShares$107 Million0.01% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.82B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...